

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 9.93804535 |
| 2 | exogenous drug catabolic process (GO:0042738) | 9.84250588 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.61442961 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.61442961 |
| 5 | regulation of plasminogen activation (GO:0010755) | 7.44759455 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.27281988 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 7.27281988 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.80540631 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.45824713 |
| 10 | drug metabolic process (GO:0017144) | 6.16332393 |
| 11 | tryptophan catabolic process (GO:0006569) | 6.09251237 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 6.09251237 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 6.09251237 |
| 14 | ethanol metabolic process (GO:0006067) | 6.00367634 |
| 15 | kynurenine metabolic process (GO:0070189) | 5.98706038 |
| 16 | bile acid biosynthetic process (GO:0006699) | 5.88932933 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 5.84098599 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.82853868 |
| 19 | oxidative demethylation (GO:0070989) | 5.74694040 |
| 20 | tryptophan metabolic process (GO:0006568) | 5.74223022 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.73369462 |
| 22 | urea cycle (GO:0000050) | 5.67388725 |
| 23 | urea metabolic process (GO:0019627) | 5.67388725 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.62398266 |
| 25 | opsonization (GO:0008228) | 5.61722536 |
| 26 | alpha-linolenic acid metabolic process (GO:0036109) | 5.58953144 |
| 27 | complement activation, alternative pathway (GO:0006957) | 5.44649168 |
| 28 | protein carboxylation (GO:0018214) | 5.44627081 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.44627081 |
| 30 | regulation of protein activation cascade (GO:2000257) | 5.42512729 |
| 31 | sulfur amino acid catabolic process (GO:0000098) | 5.31022707 |
| 32 | cysteine metabolic process (GO:0006534) | 5.29064754 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 5.20887979 |
| 34 | S-adenosylmethionine metabolic process (GO:0046500) | 5.15725424 |
| 35 | serine family amino acid catabolic process (GO:0009071) | 5.11747516 |
| 36 | reverse cholesterol transport (GO:0043691) | 5.05179335 |
| 37 | bile acid metabolic process (GO:0008206) | 5.04535775 |
| 38 | regulation of complement activation (GO:0030449) | 5.04429094 |
| 39 | regulation of cholesterol esterification (GO:0010872) | 4.99653650 |
| 40 | aromatic amino acid family metabolic process (GO:0009072) | 4.93686458 |
| 41 | regulation of triglyceride catabolic process (GO:0010896) | 4.91839525 |
| 42 | plasma lipoprotein particle remodeling (GO:0034369) | 4.91563621 |
| 43 | protein-lipid complex remodeling (GO:0034368) | 4.91563621 |
| 44 | macromolecular complex remodeling (GO:0034367) | 4.91563621 |
| 45 | tyrosine metabolic process (GO:0006570) | 4.86231146 |
| 46 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.80346616 |
| 47 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.75528449 |
| 48 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.75528449 |
| 49 | homocysteine metabolic process (GO:0050667) | 4.73591422 |
| 50 | regulation of humoral immune response (GO:0002920) | 4.69423105 |
| 51 | phospholipid efflux (GO:0033700) | 4.68102387 |
| 52 | acylglycerol homeostasis (GO:0055090) | 4.67303465 |
| 53 | triglyceride homeostasis (GO:0070328) | 4.67303465 |
| 54 | alpha-amino acid catabolic process (GO:1901606) | 4.62955748 |
| 55 | amino-acid betaine metabolic process (GO:0006577) | 4.59596974 |
| 56 | negative regulation of sterol transport (GO:0032372) | 4.56491206 |
| 57 | negative regulation of cholesterol transport (GO:0032375) | 4.56491206 |
| 58 | lysine catabolic process (GO:0006554) | 4.56381080 |
| 59 | lysine metabolic process (GO:0006553) | 4.56381080 |
| 60 | cellular ketone body metabolic process (GO:0046950) | 4.55976534 |
| 61 | phenylpropanoid metabolic process (GO:0009698) | 4.50300348 |
| 62 | plasma lipoprotein particle clearance (GO:0034381) | 4.49564837 |
| 63 | glycine metabolic process (GO:0006544) | 4.43541296 |
| 64 | bile acid and bile salt transport (GO:0015721) | 4.35057462 |
| 65 | cholesterol efflux (GO:0033344) | 4.34526112 |
| 66 | indolalkylamine metabolic process (GO:0006586) | 4.31233437 |
| 67 | imidazole-containing compound metabolic process (GO:0052803) | 4.30256754 |
| 68 | coenzyme catabolic process (GO:0009109) | 4.28078699 |
| 69 | negative regulation of blood coagulation (GO:0030195) | 4.28024097 |
| 70 | negative regulation of hemostasis (GO:1900047) | 4.28024097 |
| 71 | cellular amino acid catabolic process (GO:0009063) | 4.24534214 |
| 72 | glutamate metabolic process (GO:0006536) | 4.23119638 |
| 73 | amine catabolic process (GO:0009310) | 4.21800018 |
| 74 | cellular biogenic amine catabolic process (GO:0042402) | 4.21800018 |
| 75 | serine family amino acid metabolic process (GO:0009069) | 4.15039508 |
| 76 | plasma lipoprotein particle assembly (GO:0034377) | 4.14947894 |
| 77 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.14427017 |
| 78 | fibrinolysis (GO:0042730) | 4.14063590 |
| 79 | L-serine metabolic process (GO:0006563) | 4.11713156 |
| 80 | cellular glucuronidation (GO:0052695) | 4.09411530 |
| 81 | benzene-containing compound metabolic process (GO:0042537) | 4.08209897 |
| 82 | arginine metabolic process (GO:0006525) | 4.07397837 |
| 83 | low-density lipoprotein particle remodeling (GO:0034374) | 4.05079593 |
| 84 | cellular modified amino acid catabolic process (GO:0042219) | 4.03248838 |
| 85 | blood coagulation, intrinsic pathway (GO:0007597) | 4.02425982 |
| 86 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.02312409 |
| 87 | aldehyde catabolic process (GO:0046185) | 4.02030012 |
| 88 | serine family amino acid biosynthetic process (GO:0009070) | 4.01073003 |
| 89 | drug catabolic process (GO:0042737) | 3.97595711 |
| 90 | ethanol oxidation (GO:0006069) | 3.95290286 |
| 91 | ketone body metabolic process (GO:1902224) | 3.94545329 |
| 92 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.89239167 |
| 93 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.89239167 |
| 94 | tetrahydrofolate metabolic process (GO:0046653) | 3.87289376 |
| 95 | negative regulation of coagulation (GO:0050819) | 3.83089659 |
| 96 | cofactor catabolic process (GO:0051187) | 3.82209524 |
| 97 | negative regulation of lipase activity (GO:0060192) | 3.82181730 |
| 98 | response to mercury ion (GO:0046689) | 3.81211945 |
| 99 | phospholipid homeostasis (GO:0055091) | 3.81194165 |
| 100 | protein activation cascade (GO:0072376) | 3.80266441 |
| 101 | positive regulation of lipid catabolic process (GO:0050996) | 3.79146922 |
| 102 | cholesterol homeostasis (GO:0042632) | 3.78164791 |
| 103 | negative regulation of wound healing (GO:0061045) | 3.78039509 |
| 104 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.77989216 |
| 105 | complement activation, classical pathway (GO:0006958) | 3.77653230 |
| 106 | complement activation (GO:0006956) | 3.77319793 |
| 107 | plasma lipoprotein particle organization (GO:0071827) | 3.76110953 |
| 108 | oxaloacetate metabolic process (GO:0006107) | 3.74575019 |
| 109 | sterol homeostasis (GO:0055092) | 3.71673854 |
| 110 | organic acid catabolic process (GO:0016054) | 3.71186958 |
| 111 | carboxylic acid catabolic process (GO:0046395) | 3.71186958 |
| 112 | protein-lipid complex assembly (GO:0065005) | 3.70773866 |
| 113 | regulation of bile acid biosynthetic process (GO:0070857) | 3.64941344 |
| 114 | glucuronate metabolic process (GO:0019585) | 3.62545067 |
| 115 | uronic acid metabolic process (GO:0006063) | 3.62545067 |
| 116 | regulation of cholesterol homeostasis (GO:2000188) | 3.59972047 |
| 117 | heme transport (GO:0015886) | 3.59897857 |
| 118 | acute-phase response (GO:0006953) | 3.59284141 |
| 119 | cytolysis (GO:0019835) | 3.59020403 |
| 120 | negative regulation of protein activation cascade (GO:2000258) | 3.58963959 |
| 121 | acetyl-CoA metabolic process (GO:0006084) | 3.58044223 |
| 122 | positive regulation of blood coagulation (GO:0030194) | 3.52579081 |
| 123 | positive regulation of hemostasis (GO:1900048) | 3.52579081 |
| 124 | xenobiotic catabolic process (GO:0042178) | 3.44082498 |
| 125 | negative regulation of complement activation (GO:0045916) | 3.43889481 |
| 126 | alkaloid metabolic process (GO:0009820) | 3.42976573 |
| 127 | hormone catabolic process (GO:0042447) | 3.37487180 |
| 128 | regulation of acute inflammatory response (GO:0002673) | 3.35720226 |
| 129 | sodium-independent organic anion transport (GO:0043252) | 3.35685420 |
| 130 | sulfur amino acid metabolic process (GO:0000096) | 3.30243419 |
| 131 | xenobiotic metabolic process (GO:0006805) | 3.28676858 |
| 132 | primary alcohol metabolic process (GO:0034308) | 3.27777871 |
| 133 | folic acid-containing compound metabolic process (GO:0006760) | 3.26009046 |
| 134 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.23098138 |
| 135 | omega-hydroxylase P450 pathway (GO:0097267) | 10.1734601 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.43552500 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.22413621 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.97472231 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.51792461 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.33319706 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.20513661 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.88442666 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.05860766 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.02938572 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08488124 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.1189792 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.99348451 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.91472934 |
| 14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.84530254 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 1.65601944 |
| 16 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61713247 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.57607815 |
| 18 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.56807005 |
| 19 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.43324249 |
| 20 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40903800 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39319531 |
| 22 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.33895966 |
| 23 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.27189573 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.25093557 |
| 25 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.19744786 |
| 26 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.19520196 |
| 27 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19492991 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.14835651 |
| 29 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.12072206 |
| 30 | NFYA_21822215_ChIP-Seq_K562_Human | 1.09870794 |
| 31 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.07493899 |
| 32 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00043372 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.97880651 |
| 34 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.97229348 |
| 35 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96956875 |
| 36 | NFYB_21822215_ChIP-Seq_K562_Human | 0.96902232 |
| 37 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.96752331 |
| 38 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94452850 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.93568345 |
| 40 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90908539 |
| 41 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.89819278 |
| 42 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.89367237 |
| 43 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.88479962 |
| 44 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88283715 |
| 45 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.88084168 |
| 46 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.87563521 |
| 47 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.86001254 |
| 48 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.84594854 |
| 49 | TBL1_22424771_ChIP-Seq_293T_Human | 0.82917529 |
| 50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.81608539 |
| 51 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81126539 |
| 52 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.81106734 |
| 53 | P300_27268052_Chip-Seq_Bcells_Human | 0.80075926 |
| 54 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79841541 |
| 55 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.79839499 |
| 56 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79345050 |
| 57 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78799136 |
| 58 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.78460059 |
| 59 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78459949 |
| 60 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.78140509 |
| 61 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.77814338 |
| 62 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75735618 |
| 63 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.75700966 |
| 64 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.74953154 |
| 65 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.74166371 |
| 66 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73541891 |
| 67 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.72685051 |
| 68 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.72493980 |
| 69 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72130145 |
| 70 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.71866027 |
| 71 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.71414392 |
| 72 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.70836298 |
| 73 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69963054 |
| 74 | VDR_22108803_ChIP-Seq_LS180_Human | 0.69722750 |
| 75 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68338604 |
| 76 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.68256363 |
| 77 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.68058086 |
| 78 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.67352066 |
| 79 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67346448 |
| 80 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.67276459 |
| 81 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.66318361 |
| 82 | P68_20966046_ChIP-Seq_HELA_Human | 0.65904025 |
| 83 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65375327 |
| 84 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.65348490 |
| 85 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.65245602 |
| 86 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.64376466 |
| 87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64328103 |
| 88 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.63556996 |
| 89 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63455546 |
| 90 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.62640889 |
| 91 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62469245 |
| 92 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.62389431 |
| 93 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.61796481 |
| 94 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.61048631 |
| 95 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60948621 |
| 96 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.60185861 |
| 97 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.60185861 |
| 98 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.59980321 |
| 99 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59947284 |
| 100 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.59400899 |
| 101 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.59104154 |
| 102 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.59035583 |
| 103 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.58512630 |
| 104 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.58437055 |
| 105 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.58124692 |
| 106 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57466441 |
| 107 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55816693 |
| 108 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.55370516 |
| 109 | GATA1_19941826_ChIP-Seq_K562_Human | 0.55243512 |
| 110 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.52555393 |
| 111 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51864969 |
| 112 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51827540 |
| 113 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.51094735 |
| 114 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51015001 |
| 115 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50628282 |
| 116 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.49412782 |
| 117 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.49384199 |
| 118 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48978979 |
| 119 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48633752 |
| 120 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46650562 |
| 121 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.45451509 |
| 122 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.44766243 |
| 123 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.43993898 |
| 124 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.43283962 |
| 125 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.43153359 |
| 126 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42856353 |
| 127 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42804720 |
| 128 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.42790348 |
| 129 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40528195 |
| 130 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.39494670 |
| 131 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.38924740 |
| 132 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.38591933 |
| 133 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37956204 |
| 134 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.37668114 |
| 135 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.37520881 |
| 136 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.37506149 |
| 137 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.36719017 |
| 138 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.36428567 |
| 139 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.35970410 |
| 140 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.35943551 |
| 141 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35380003 |
| 142 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.35195903 |
| 143 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.35039715 |
| 144 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.35004533 |
| 145 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.34832948 |
| 146 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.33967163 |
| 147 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.33645169 |
| 148 | NCOR_22424771_ChIP-Seq_293T_Human | 0.33268144 |
| 149 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.32730553 |
| 150 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.32574571 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.24266149 |
| 2 | MP0005360_urolithiasis | 7.51574629 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.43620683 |
| 4 | MP0005365_abnormal_bile_salt | 6.14568635 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.18186404 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.12834679 |
| 7 | MP0003252_abnormal_bile_duct | 3.87079138 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.63123455 |
| 9 | MP0009840_abnormal_foam_cell | 3.31603610 |
| 10 | MP0005083_abnormal_biliary_tract | 3.18430163 |
| 11 | MP0003195_calcinosis | 2.82557318 |
| 12 | MP0005332_abnormal_amino_acid | 2.73571723 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.58113723 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.48181220 |
| 15 | MP0000609_abnormal_liver_physiology | 2.18847868 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.14909775 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.10162880 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.94807486 |
| 19 | MP0003868_abnormal_feces_composition | 1.89742215 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.83775129 |
| 21 | MP0001764_abnormal_homeostasis | 1.67144985 |
| 22 | MP0009697_abnormal_copulation | 1.60639642 |
| 23 | MP0003011_delayed_dark_adaptation | 1.59447551 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57307866 |
| 25 | MP0003656_abnormal_erythrocyte_physiolo | 1.52870964 |
| 26 | MP0005451_abnormal_body_composition | 1.45517875 |
| 27 | MP0008995_early_reproductive_senescence | 1.34085931 |
| 28 | MP0005646_abnormal_pituitary_gland | 1.30423431 |
| 29 | MP0003186_abnormal_redox_activity | 1.27203125 |
| 30 | MP0009643_abnormal_urine_homeostasis | 1.22005300 |
| 31 | MP0000598_abnormal_liver_morphology | 1.20696799 |
| 32 | MP0003705_abnormal_hypodermis_morpholog | 1.18827616 |
| 33 | MP0005647_abnormal_sex_gland | 1.11414025 |
| 34 | MP0010368_abnormal_lymphatic_system | 1.10186006 |
| 35 | MP0000604_amyloidosis | 1.10174165 |
| 36 | MP0002254_reproductive_system_inflammat | 1.05264977 |
| 37 | MP0009764_decreased_sensitivity_to | 1.04869514 |
| 38 | MP0009763_increased_sensitivity_to | 1.03713842 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 0.96384884 |
| 40 | MP0003183_abnormal_peptide_metabolism | 0.92137402 |
| 41 | MP0002282_abnormal_trachea_morphology | 0.91792750 |
| 42 | MP0008775_abnormal_heart_ventricle | 0.90316884 |
| 43 | MP0008469_abnormal_protein_level | 0.89756119 |
| 44 | MP0009642_abnormal_blood_homeostasis | 0.87774241 |
| 45 | MP0005670_abnormal_white_adipose | 0.87250143 |
| 46 | MP0006036_abnormal_mitochondrial_physio | 0.83199621 |
| 47 | MP0005408_hypopigmentation | 0.81502496 |
| 48 | MP0005376_homeostasis/metabolism_phenot | 0.80651222 |
| 49 | MP0009765_abnormal_xenobiotic_induced | 0.78002626 |
| 50 | MP0002078_abnormal_glucose_homeostasis | 0.77895705 |
| 51 | MP0002249_abnormal_larynx_morphology | 0.77616950 |
| 52 | MP0005084_abnormal_gallbladder_morpholo | 0.74294582 |
| 53 | MP0000013_abnormal_adipose_tissue | 0.73436105 |
| 54 | MP0005220_abnormal_exocrine_pancreas | 0.72902720 |
| 55 | MP0002971_abnormal_brown_adipose | 0.71874405 |
| 56 | MP0001661_extended_life_span | 0.71392998 |
| 57 | MP0002876_abnormal_thyroid_physiology | 0.69627324 |
| 58 | MP0009053_abnormal_anal_canal | 0.68654373 |
| 59 | MP0004130_abnormal_muscle_cell | 0.68424867 |
| 60 | MP0003690_abnormal_glial_cell | 0.66766108 |
| 61 | MP0005334_abnormal_fat_pad | 0.66666292 |
| 62 | MP0000678_abnormal_parathyroid_gland | 0.65685761 |
| 63 | MP0005535_abnormal_body_temperature | 0.65296276 |
| 64 | MP0003879_abnormal_hair_cell | 0.63902787 |
| 65 | MP0005266_abnormal_metabolism | 0.63714860 |
| 66 | MP0000639_abnormal_adrenal_gland | 0.63409222 |
| 67 | MP0001851_eye_inflammation | 0.61869969 |
| 68 | MP0003329_amyloid_beta_deposits | 0.60337098 |
| 69 | MP0005464_abnormal_platelet_physiology | 0.60333895 |
| 70 | MP0001756_abnormal_urination | 0.59889434 |
| 71 | MP0002736_abnormal_nociception_after | 0.58226147 |
| 72 | MP0005448_abnormal_energy_balance | 0.56514800 |
| 73 | MP0006035_abnormal_mitochondrial_morpho | 0.55951386 |
| 74 | MP0002295_abnormal_pulmonary_circulatio | 0.52137330 |
| 75 | MP0004145_abnormal_muscle_electrophysio | 0.52005683 |
| 76 | MP0002332_abnormal_exercise_endurance | 0.51738584 |
| 77 | MP0005187_abnormal_penis_morphology | 0.49846739 |
| 78 | MP0005395_other_phenotype | 0.48850700 |
| 79 | MP0004036_abnormal_muscle_relaxation | 0.48822637 |
| 80 | MP0003638_abnormal_response/metabolism_ | 0.46037565 |
| 81 | MP0008874_decreased_physiological_sensi | 0.45739938 |
| 82 | MP0008873_increased_physiological_sensi | 0.45532748 |
| 83 | MP0004782_abnormal_surfactant_physiolog | 0.45341684 |
| 84 | MP0002928_abnormal_bile_duct | 0.44836022 |
| 85 | MP0003718_maternal_effect | 0.44742839 |
| 86 | MP0002822_catalepsy | 0.44261390 |
| 87 | MP0003436_decreased_susceptibility_to | 0.44231510 |
| 88 | MP0002136_abnormal_kidney_physiology | 0.44113861 |
| 89 | MP0001944_abnormal_pancreas_morphology | 0.43806363 |
| 90 | MP0005248_abnormal_Harderian_gland | 0.43577909 |
| 91 | MP0002837_dystrophic_cardiac_calcinosis | 0.42360995 |
| 92 | MP0008872_abnormal_physiological_respon | 0.42212998 |
| 93 | MP0004084_abnormal_cardiac_muscle | 0.40506484 |
| 94 | MP0003075_altered_response_to | 0.40427848 |
| 95 | MP0003724_increased_susceptibility_to | 0.40256417 |
| 96 | MP0003953_abnormal_hormone_level | 0.39628420 |
| 97 | MP0005385_cardiovascular_system_phenoty | 0.39572026 |
| 98 | MP0001544_abnormal_cardiovascular_syste | 0.39572026 |
| 99 | MP0005330_cardiomyopathy | 0.39302794 |
| 100 | MP0009672_abnormal_birth_weight | 0.39302704 |
| 101 | MP0005397_hematopoietic_system_phenotyp | 0.38926811 |
| 102 | MP0001545_abnormal_hematopoietic_system | 0.38926811 |
| 103 | MP0009384_cardiac_valve_regurgitation | 0.38627902 |
| 104 | MP0005666_abnormal_adipose_tissue | 0.37174090 |
| 105 | MP0002269_muscular_atrophy | 0.36287971 |
| 106 | MP0005023_abnormal_wound_healing | 0.36231589 |
| 107 | MP0004883_abnormal_blood_vessel | 0.35804782 |
| 108 | MP0004885_abnormal_endolymph | 0.35285331 |
| 109 | MP0005166_decreased_susceptibility_to | 0.34630168 |
| 110 | MP0009785_altered_susceptibility_to | 0.34313225 |
| 111 | MP0002128_abnormal_blood_circulation | 0.34308251 |
| 112 | MP0000249_abnormal_blood_vessel | 0.33403816 |
| 113 | MP0000371_diluted_coat_color | 0.32895387 |
| 114 | MP0001243_abnormal_dermal_layer | 0.32654442 |
| 115 | MP0009115_abnormal_fat_cell | 0.32275518 |
| 116 | MP0000230_abnormal_systemic_arterial | 0.32074185 |
| 117 | MP0010630_abnormal_cardiac_muscle | 0.31784184 |
| 118 | MP0001915_intracranial_hemorrhage | 0.31456549 |
| 119 | MP0000579_abnormal_nail_morphology | 0.30851453 |
| 120 | MP0002970_abnormal_white_adipose | 0.30716812 |
| 121 | MP0004381_abnormal_hair_follicle | 0.30495705 |
| 122 | MP0004147_increased_porphyrin_level | 0.30476106 |
| 123 | MP0002168_other_aberrant_phenotype | 0.30391144 |
| 124 | MP0005551_abnormal_eye_electrophysiolog | 0.29282923 |
| 125 | MP0002796_impaired_skin_barrier | 0.29201571 |
| 126 | MP0005164_abnormal_response_to | 0.28272879 |
| 127 | MP0002090_abnormal_vision | 0.28051424 |
| 128 | MP0001853_heart_inflammation | 0.27730248 |
| 129 | MP0001845_abnormal_inflammatory_respons | 0.27327163 |
| 130 | MP0006082_CNS_inflammation | 0.26541256 |
| 131 | MP0002132_abnormal_respiratory_system | 0.26179268 |
| 132 | MP0001881_abnormal_mammary_gland | 0.25292809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.57825964 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.42426689 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.24127680 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.73855098 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.67559083 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.41224962 |
| 7 | Xanthomatosis (HP:0000991) | 6.30383807 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.61232613 |
| 9 | Complement deficiency (HP:0004431) | 5.42397639 |
| 10 | Joint hemorrhage (HP:0005261) | 4.94878727 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.91648529 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.61505083 |
| 13 | Hyperammonemia (HP:0001987) | 4.58322899 |
| 14 | Abnormality of alanine metabolism (HP:0010916) | 4.50021224 |
| 15 | Hyperalaninemia (HP:0003348) | 4.50021224 |
| 16 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 4.50021224 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.47967821 |
| 18 | Epidermoid cyst (HP:0200040) | 4.44942171 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 4.40963676 |
| 20 | Abnormality of methionine metabolism (HP:0010901) | 4.33264360 |
| 21 | Hyperglycinemia (HP:0002154) | 4.30236444 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.24628593 |
| 23 | Ketosis (HP:0001946) | 4.24102536 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.12608684 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.08716439 |
| 26 | Fat malabsorption (HP:0002630) | 4.03318547 |
| 27 | Abnormality of complement system (HP:0005339) | 3.96638106 |
| 28 | Abnormality of the intrinsic pathway (HP:0010989) | 3.85392478 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.85304107 |
| 30 | Hypoglycemic coma (HP:0001325) | 3.84543316 |
| 31 | Hyperglycinuria (HP:0003108) | 3.80846243 |
| 32 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.80832865 |
| 33 | Abnormality of glycine metabolism (HP:0010895) | 3.80832865 |
| 34 | Conjugated hyperbilirubinemia (HP:0002908) | 3.65467472 |
| 35 | Hypercholesterolemia (HP:0003124) | 3.61174477 |
| 36 | Hyperbilirubinemia (HP:0002904) | 3.50017267 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.30730126 |
| 38 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.28386381 |
| 39 | Hypochromic microcytic anemia (HP:0004840) | 3.27802458 |
| 40 | Spontaneous abortion (HP:0005268) | 3.22355020 |
| 41 | Purpura (HP:0000979) | 3.16288412 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 3.14935358 |
| 43 | Abnormality of nucleobase metabolism (HP:0010932) | 3.05059018 |
| 44 | Delayed CNS myelination (HP:0002188) | 3.03042610 |
| 45 | Steatorrhea (HP:0002570) | 3.02515794 |
| 46 | Abnormality of serum amino acid levels (HP:0003112) | 3.00184418 |
| 47 | Ketoacidosis (HP:0001993) | 2.93801065 |
| 48 | Myocardial infarction (HP:0001658) | 2.91409682 |
| 49 | Metabolic acidosis (HP:0001942) | 2.77479864 |
| 50 | Systemic lupus erythematosus (HP:0002725) | 2.76864387 |
| 51 | Skin nodule (HP:0200036) | 2.76634919 |
| 52 | Acanthocytosis (HP:0001927) | 2.74381269 |
| 53 | Abnormal gallbladder morphology (HP:0012437) | 2.65598703 |
| 54 | Abnormality of purine metabolism (HP:0004352) | 2.64936474 |
| 55 | Cholelithiasis (HP:0001081) | 2.61471528 |
| 56 | Vascular calcification (HP:0004934) | 2.58377747 |
| 57 | Lethargy (HP:0001254) | 2.58354052 |
| 58 | Glomerulonephritis (HP:0000099) | 2.58030464 |
| 59 | Neonatal hypoglycemia (HP:0001998) | 2.54520283 |
| 60 | Cholecystitis (HP:0001082) | 2.53087021 |
| 61 | Abnormal gallbladder physiology (HP:0012438) | 2.53087021 |
| 62 | Elevated alkaline phosphatase (HP:0003155) | 2.52530491 |
| 63 | Abnormality of homocysteine metabolism (HP:0010919) | 2.51411535 |
| 64 | Homocystinuria (HP:0002156) | 2.51411535 |
| 65 | Anorexia (HP:0002039) | 2.50609624 |
| 66 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.50229593 |
| 67 | Dicarboxylic aciduria (HP:0003215) | 2.50229593 |
| 68 | Congenital sensorineural hearing impairment (HP:0008527) | 2.48907389 |
| 69 | Mitral stenosis (HP:0001718) | 2.46844149 |
| 70 | Hypoglycemic seizures (HP:0002173) | 2.46552711 |
| 71 | Gout (HP:0001997) | 2.46296871 |
| 72 | Cerebral edema (HP:0002181) | 2.43729593 |
| 73 | Spastic diplegia (HP:0001264) | 2.43045352 |
| 74 | Amyloidosis (HP:0011034) | 2.41728163 |
| 75 | Hyperphosphaturia (HP:0003109) | 2.40856436 |
| 76 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.36983148 |
| 77 | Gingival bleeding (HP:0000225) | 2.36468689 |
| 78 | Irritability (HP:0000737) | 2.34042483 |
| 79 | Neonatal onset (HP:0003623) | 2.32212414 |
| 80 | Poikilocytosis (HP:0004447) | 2.31443843 |
| 81 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.29955327 |
| 82 | Cardiovascular calcification (HP:0011915) | 2.29313239 |
| 83 | Osteomalacia (HP:0002749) | 2.28434745 |
| 84 | Menorrhagia (HP:0000132) | 2.24923111 |
| 85 | Increased mean platelet volume (HP:0011877) | 2.18683873 |
| 86 | Enlarged kidneys (HP:0000105) | 2.17664508 |
| 87 | Malnutrition (HP:0004395) | 2.15353833 |
| 88 | * Pulmonary embolism (HP:0002204) | 2.13776347 |
| 89 | Brushfield spots (HP:0001088) | 2.13402893 |
| 90 | Pancreatitis (HP:0001733) | 2.12984087 |
| 91 | Abnormality of the gallbladder (HP:0005264) | 2.12743589 |
| 92 | Constricted visual fields (HP:0001133) | 2.11254739 |
| 93 | Sensorimotor neuropathy (HP:0007141) | 2.10876124 |
| 94 | Late onset (HP:0003584) | 2.09274223 |
| 95 | Vomiting (HP:0002013) | 2.07033112 |
| 96 | Hemorrhage of the eye (HP:0011885) | 2.03840438 |
| 97 | Fair hair (HP:0002286) | 2.02009565 |
| 98 | Opisthotonus (HP:0002179) | 2.01472258 |
| 99 | Generalized aminoaciduria (HP:0002909) | 1.99703759 |
| 100 | * Epistaxis (HP:0000421) | 1.99435567 |
| 101 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.98857688 |
| 102 | Abnormal platelet volume (HP:0011876) | 1.97717611 |
| 103 | Abnormality of iron homeostasis (HP:0011031) | 1.97617038 |
| 104 | Rickets (HP:0002748) | 1.93964630 |
| 105 | * Thrombophlebitis (HP:0004418) | 1.93714885 |
| 106 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92272448 |
| 107 | Reticulocytosis (HP:0001923) | 1.91536665 |
| 108 | Abnormal urine phosphate concentration (HP:0012599) | 1.91487319 |
| 109 | Abnormal cartilage morphology (HP:0002763) | 1.88340076 |
| 110 | Decreased subcutaneous fat (HP:0001002) | 1.87006207 |
| 111 | Hypophosphatemic rickets (HP:0004912) | 1.86353282 |
| 112 | Glycosuria (HP:0003076) | 1.84685286 |
| 113 | Abnormality of urine glucose concentration (HP:0011016) | 1.84685286 |
| 114 | Birth length less than 3rd percentile (HP:0003561) | 1.84551221 |
| 115 | Nephritis (HP:0000123) | 1.83065211 |
| 116 | Increased serum pyruvate (HP:0003542) | 1.82708670 |
| 117 | Renal cortical cysts (HP:0000803) | 1.80276966 |
| 118 | Abnormality of proline metabolism (HP:0010907) | 1.79338945 |
| 119 | Hydroxyprolinuria (HP:0003080) | 1.79338945 |
| 120 | Status epilepticus (HP:0002133) | 1.78346394 |
| 121 | Alkalosis (HP:0001948) | 1.78174655 |
| 122 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.76979059 |
| 123 | Acute hepatic failure (HP:0006554) | 1.74140307 |
| 124 | * Elevated hepatic transaminases (HP:0002910) | 1.73896578 |
| 125 | Abnormal tarsal ossification (HP:0008369) | 1.73581153 |
| 126 | * Esophageal varix (HP:0002040) | 1.73525781 |
| 127 | Ileus (HP:0002595) | 1.72645101 |
| 128 | Hyperglycemia (HP:0003074) | 1.70291704 |
| 129 | White forelock (HP:0002211) | 1.68526134 |
| 130 | Back pain (HP:0003418) | 1.67765207 |
| 131 | Arthropathy (HP:0003040) | 1.67750086 |
| 132 | Arterial thrombosis (HP:0004420) | 1.64030360 |
| 133 | Abnormal platelet function (HP:0011869) | 1.63648611 |
| 134 | Impaired platelet aggregation (HP:0003540) | 1.63648611 |
| 135 | Petechiae (HP:0000967) | 1.62227687 |
| 136 | Atrioventricular block (HP:0001678) | 1.59829925 |
| 137 | Hypoparathyroidism (HP:0000829) | 1.59458321 |
| 138 | Abnormality of glycolysis (HP:0004366) | 1.58947250 |
| 139 | Metaphyseal cupping (HP:0003021) | 1.58475298 |
| 140 | Cerebral palsy (HP:0100021) | 1.56691945 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.16899021 |
| 2 | FGFR4 | 4.68165476 |
| 3 | ERN1 | 4.49142537 |
| 4 | SIK1 | 4.45358204 |
| 5 | NTRK3 | 3.80429549 |
| 6 | JAK3 | 3.48064841 |
| 7 | RPS6KB2 | 3.24413874 |
| 8 | TAOK3 | 3.03816354 |
| 9 | INSRR | 2.90749793 |
| 10 | ERBB4 | 2.86956226 |
| 11 | ACVR1B | 2.54780597 |
| 12 | MAP2K4 | 2.37551142 |
| 13 | PKN2 | 2.28171213 |
| 14 | MST1R | 2.21190055 |
| 15 | RIPK4 | 2.20041799 |
| 16 | CDK9 | 2.18798170 |
| 17 | FGR | 2.17340604 |
| 18 | MAPK11 | 1.98286775 |
| 19 | FLT3 | 1.91170216 |
| 20 | CCNB1 | 1.87736068 |
| 21 | NTRK2 | 1.84006757 |
| 22 | TRIB3 | 1.82166089 |
| 23 | TYK2 | 1.81313155 |
| 24 | MYLK | 1.75719699 |
| 25 | DAPK2 | 1.62326385 |
| 26 | PIK3CG | 1.62153279 |
| 27 | LATS1 | 1.51766653 |
| 28 | ABL2 | 1.49243154 |
| 29 | PTK6 | 1.48286873 |
| 30 | KDR | 1.47471000 |
| 31 | EPHA3 | 1.45822773 |
| 32 | OBSCN | 1.42963927 |
| 33 | NEK9 | 1.39418791 |
| 34 | MAPKAPK3 | 1.38288812 |
| 35 | FRK | 1.34806259 |
| 36 | PINK1 | 1.33802993 |
| 37 | EPHB2 | 1.32762898 |
| 38 | LMTK2 | 1.31862185 |
| 39 | FGFR2 | 1.31460216 |
| 40 | MAP2K3 | 1.27520083 |
| 41 | JAK2 | 1.26041795 |
| 42 | MAP4K1 | 1.23716050 |
| 43 | GRK7 | 1.17045226 |
| 44 | GRK6 | 1.14470774 |
| 45 | MAP3K7 | 1.14205770 |
| 46 | PRKAA2 | 1.13553777 |
| 47 | ERBB2 | 1.11071771 |
| 48 | ADRBK1 | 1.06801766 |
| 49 | STK38L | 1.03200807 |
| 50 | JAK1 | 1.01715359 |
| 51 | MAPK4 | 0.97444181 |
| 52 | TESK2 | 0.96414201 |
| 53 | TBK1 | 0.96401228 |
| 54 | BMPR2 | 0.95883720 |
| 55 | EPHB1 | 0.95571634 |
| 56 | TIE1 | 0.90753429 |
| 57 | MAP3K3 | 0.90539713 |
| 58 | PRKCZ | 0.89946312 |
| 59 | MET | 0.88071510 |
| 60 | MAPK12 | 0.86207039 |
| 61 | MAP3K10 | 0.85876474 |
| 62 | KSR2 | 0.85685314 |
| 63 | CDC7 | 0.85425239 |
| 64 | MAP3K11 | 0.84914477 |
| 65 | PBK | 0.81754598 |
| 66 | MAP3K14 | 0.81244441 |
| 67 | TEC | 0.80907761 |
| 68 | PRKACG | 0.80491561 |
| 69 | CDK6 | 0.75653588 |
| 70 | AKT3 | 0.71355501 |
| 71 | CSK | 0.71087366 |
| 72 | RIPK1 | 0.69127990 |
| 73 | DYRK1B | 0.68917204 |
| 74 | WNK4 | 0.68680746 |
| 75 | MAPK15 | 0.67513548 |
| 76 | CAMK2G | 0.67105724 |
| 77 | BLK | 0.66755852 |
| 78 | PAK4 | 0.65992732 |
| 79 | SGK3 | 0.65048147 |
| 80 | PRKAA1 | 0.64919799 |
| 81 | TGFBR2 | 0.63820481 |
| 82 | GSK3A | 0.62912186 |
| 83 | MAP2K6 | 0.61937659 |
| 84 | RPS6KB1 | 0.61476768 |
| 85 | AURKA | 0.61187401 |
| 86 | CDK7 | 0.60642982 |
| 87 | CAMK1D | 0.60482641 |
| 88 | BRSK2 | 0.60092668 |
| 89 | FGFR3 | 0.58405864 |
| 90 | MAPK7 | 0.57590955 |
| 91 | TNK2 | 0.57430750 |
| 92 | RAF1 | 0.56616587 |
| 93 | CSNK1A1 | 0.55681937 |
| 94 | PRKD1 | 0.53812773 |
| 95 | TRPM7 | 0.53423228 |
| 96 | PTK2 | 0.52961571 |
| 97 | CAMK1 | 0.52749469 |
| 98 | CSF1R | 0.51871758 |
| 99 | PAK1 | 0.50977528 |
| 100 | SGK1 | 0.50410067 |
| 101 | SGK2 | 0.48138737 |
| 102 | NEK6 | 0.47131942 |
| 103 | IKBKE | 0.46914451 |
| 104 | PRKCQ | 0.46675857 |
| 105 | DYRK2 | 0.46606493 |
| 106 | EPHA4 | 0.46479273 |
| 107 | GRK1 | 0.46394502 |
| 108 | PDPK1 | 0.45131627 |
| 109 | TAOK2 | 0.44732820 |
| 110 | CDK4 | 0.44698448 |
| 111 | MAP3K5 | 0.41672898 |
| 112 | IGF1R | 0.41129462 |
| 113 | CSNK1G1 | 0.40891769 |
| 114 | AKT2 | 0.40472130 |
| 115 | RET | 0.39885049 |
| 116 | PRKCG | 0.39357928 |
| 117 | MAP2K1 | 0.39215802 |
| 118 | CSNK2A1 | 0.38956613 |
| 119 | PKN1 | 0.38415999 |
| 120 | HIPK2 | 0.37476720 |
| 121 | MTOR | 0.36474149 |
| 122 | SGK494 | 0.35388457 |
| 123 | SGK223 | 0.35388457 |
| 124 | SRC | 0.35020615 |
| 125 | IRAK3 | 0.35015213 |
| 126 | ICK | 0.34984121 |
| 127 | CAMK2D | 0.34718380 |
| 128 | MATK | 0.34652453 |
| 129 | MAP3K6 | 0.34594459 |
| 130 | PRKG1 | 0.34302421 |
| 131 | BTK | 0.34088417 |
| 132 | SYK | 0.33654874 |
| 133 | EGFR | 0.32569396 |
| 134 | MAP3K13 | 0.32542157 |
| 135 | MAP3K1 | 0.31728636 |
| 136 | CAMK4 | 0.29552156 |
| 137 | DAPK1 | 0.28625402 |
| 138 | PRKCA | 0.26230966 |
| 139 | PDK1 | 0.26138822 |
| 140 | LATS2 | 0.22952791 |
| 141 | EIF2AK1 | 0.21287917 |
| 142 | CSNK1G2 | 0.19618805 |
| 143 | MAPK3 | 0.18793984 |
| 144 | PRKACB | 0.18717153 |
| 145 | ABL1 | 0.17993071 |
| 146 | BMX | 0.17728615 |
| 147 | CSNK1G3 | 0.17679765 |
| 148 | PRKACA | 0.16214942 |
| 149 | PIK3CA | 0.16143075 |
| 150 | RPS6KA3 | 0.16027488 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.49730540 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.69031128 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.47480101 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.28386510 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.09280335 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.86989518 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.68680079 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.66758317 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63463305 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.57899684 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47006799 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.35513508 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.18671824 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.13741042 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09877764 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.05126011 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.92899142 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.90531565 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.88903737 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.88504424 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86660803 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.86529720 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.83770841 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80915875 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76534179 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74665014 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.73183677 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.68492078 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67823980 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.66380370 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.60848185 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58520885 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.57414266 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.54077340 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.53345520 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.49319852 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44008423 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35312533 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.33665075 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32779311 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32575368 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.25587925 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23544604 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.21953806 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.20123808 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19243189 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16917450 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14103914 |
| 49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.09783917 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02844323 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.01999335 |
| 52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.01522873 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00466815 |
| 54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96240456 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95800067 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87446162 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86484892 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85435737 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.80413127 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.80030534 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71792665 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65114947 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63410358 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58887233 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50730140 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.48620180 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46163909 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38808538 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.33979762 |
| 70 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.30754863 |
| 71 | Pertussis_Homo sapiens_hsa05133 | 0.30706057 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26265321 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25521752 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24227059 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.23028782 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.22784066 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21871513 |
| 78 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21594384 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14915692 |
| 80 | GABAergic synapse_Homo sapiens_hsa04727 | 0.13573411 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10788671 |
| 82 | Mineral absorption_Homo sapiens_hsa04978 | 0.07506049 |
| 83 | Other glycan degradation_Homo sapiens_hsa00511 | 0.05017866 |
| 84 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.02343052 |
| 85 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02125426 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | -0.2562487 |
| 87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2513758 |
| 88 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2431134 |
| 89 | Bladder cancer_Homo sapiens_hsa05219 | -0.2414438 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2238299 |
| 91 | Glutamatergic synapse_Homo sapiens_hsa04724 | -0.2045368 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1944763 |
| 93 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1882178 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1848281 |
| 95 | Nicotine addiction_Homo sapiens_hsa05033 | -0.1837241 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | -0.1834599 |
| 97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1713218 |
| 98 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | -0.1637894 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1632146 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1604897 |
| 101 | Platelet activation_Homo sapiens_hsa04611 | -0.1599671 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1593154 |
| 103 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1523344 |
| 104 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1503710 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1400862 |
| 106 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1247559 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0993134 |
| 108 | Morphine addiction_Homo sapiens_hsa05032 | -0.0980582 |
| 109 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0898667 |
| 110 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0836440 |
| 111 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0770338 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0713090 |
| 113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0399783 |

